Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Characterizing industry payments for FDA-approved AI medical devices
0
Zitationen
3
Autoren
2025
Jahr
Abstract
Industry payments for AIMDs are increasing and concentrated among technology-intensive specialties. Payments are more likely to flow to clinicians affiliated with teaching hospitals that are larger and in non-rural areas. This may reflect or mediate increased AI utilization in these settings. Continued monitoring of payments, transparent reporting, and targeted resource support may be needed to promote equitable access to AIMDs.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.245 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.102 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.468 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.429 Zit.